No Data
Zhejiang Hengtong Holdings Co., Ltd. announced industry-related operating data for the first three quarters of 2024
Zhejiang Hengtong Holdings Co., Ltd. Report for the Third Quarter of 2024
Hengtong Co., Ltd. (600226.SH): Baikes Biotechnology plans to sign a Real Estate Transfer Agreement with Jie Xin Technology.
On September 20th, Getlonghui announced that in order to further optimize its asset structure and meet the company's development needs, its wholly-owned subsidiary Baikeseng Biology plans to transfer a house building (including land use rights) located at No. 97 Hengtangqiao Road, Zhongguan Town, Deqing County, Huzhou City, Zhejiang Province to its affiliated company Jiexin Technology. Baikeseng Biology plans to sign the Real Estate Transfer Contract with Jiexin Technology. The transfer price of this transaction is determined through negotiation between the two parties based on the asset evaluation result, which is RMB 30.3234 million.
Express News | Hengtong Corporation: Wholly-owned subsidiary intends to sell assets to affiliated party for 30.3234 million yuan.
Zhejiang Hengtong Holdings Co., Ltd. 2024 Interim Report
Summary of the 2024 interim report of Zhejiang Hangtong Holdings Co., Ltd.
No Data
No Data